Table 3 Multivariate analysis of factors associated with OS and PFS in 168 glioma patients
From: Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
Factors | OS | PFS | ||
|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Age (< 60 vs. ≥60) | 2.141 (1.143–4.012) | 0.017 | 2.241 (1.350–3.721) | 0.002 |
WHO grade (I-II vs. III-IV) | 9.723 (5.179–18.253) | 0.000 | 5.559 (3.538–8.734) | 0.000 |
Ki-67 index (< 20% vs.≥20%) | 1.018 (0.563–1.841) | 0.954 | 1.076 (0.675–1.715) | 0.757 |
MYH9 expression (Low vs. high) | 1.865 (1.065–3.266) | 0.029 | 1.203 (0.786–1.842) | 0.394 |